Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Docetaxel and S-1 Followed by Chemoradiotherapy in Locally Advanced Head and Neck Cancer
NCT00625937Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Nov 2006
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, tegafur-gimeracil-oteracil in head and neck cancer (HNC), sponsored by Yonsei University. Status: unknown.
02
Drugs
docetaxeltegafur-gimeracil-oteracil
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT00625937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00625937.